CURE will cure asthma

Monday, 11 December, 2017
Lungs' image
Asthma has become a major health and economic burden in Europe affecting 30 million Europeans and one quarter of European children. Current therapies are limited to temporary improvements of the conditions of asthmatic patients but none tackle the underlying causes of the disease. There is no cure for asthma and so far no developments are recorded for new cures but what if this complex disease requires out-of-the box thinking?

The CURE project proposes to do exactly that. In a previously EU funded project (PREDICTA) researchers from the Universities of Manchester and Athens have detected a correlation in the population changes of the bacteria and the bacterial viruses (phages) of the airways of asthmatic patients, including children. Building on this result, the CURE project proposes to test whether a new radical approach, phage therapy, could be effective in rebalancing the bacterial population of the airways, a possible underlying cause of asthma. The project will investigate how phage addition impacts the ecology of the airways and will design appropriate interventions for further use in clinical trials.

The CURE project gathers multidisciplinary expertise committed to develop new knowledge and work closely with relevant stakeholders towards a cure for asthma. The European Federation of Allergy and Airways Disease Patients' Associations (EFA) is one of the partners. The project is coordinated by the University of Athens (NKUA). If you are curious to know more about this FET-Open project's consortium, objectives and achievement, please visit CURE website.


Constructing a ‘Eubiosis Reinstatement Therapy’ for Asthma
Project Acronym: